# A Gene Therapy Study in Patients With Gaucher Disease Type 1

> **NCT05324943** · PHASE1 · COMPLETED · sponsor: **Spur Therapeutics** · enrollment: 6 (actual)

## Conditions studied

- Gaucher Disease, Type 1

## Interventions

- **GENETIC:** FLT201

## Key facts

- **NCT ID:** NCT05324943
- **Lead sponsor:** Spur Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-15
- **Primary completion:** 2024-12-04
- **Final completion:** 2024-12-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05324943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05324943, "A Gene Therapy Study in Patients With Gaucher Disease Type 1". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05324943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*